Multicenter retrospective study reveals outcomes of anti-CD19 therapy in relapsed B cell leukemia, indicating potential for improved treatment options.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: